Últimas noticias sobre ZHONGCHAO (NASDAQ:ZCMD) Bolsa

ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.

ZHONGCHAO Inc

Biotech

News

General

Envoy Medical, Inc. - Class A Common Stock

COCH

Envoy Medical Announces First Two Enrollments In Clinical Study On Fully Implanted Acclaim Cochlear Implant; Aims For Premarket Approval

Amazon.com's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NYSE">AMZN</a>) short percent of float has fallen 13.79% since its last report. The company recently reported that it has 70.76 million shares sold short, which is 0.75% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.03 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Amazon.com Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740407428_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Amazon.com has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Amazon.com's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Amazon.com's peer group average for short interest as a percentage of float is 9.94%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

AMZN

Looking Into Amazon.com's Recent Short Interest

Tesla's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NYSE">TSLA</a>) short percent of float has fallen 5.75% since its last report. The company recently reported that it has 59.61 million shares sold short, which is 2.13% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Tesla Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740407423_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Tesla has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Tesla's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Tesla's peer group average for short interest as a percentage of float is 8.58%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

TSLA

Is the Market Bullish or Bearish on Tesla?

As the iPhone maker Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) <a href="https://www.benzinga.com/tech/25/02/43910982/apple-commits-500-billion-in-us-investment-for-ai-push-boost-us-manufacturing-tech">announced its plans to invest $500 billion</a> in the U.S. over the next four years, this expert says that the technology giant was "forced to kiss the ring," in his latest post.
What Happened: President Donald Trump at a meeting with the U.S. governors over the weekend announced that Apple&#8217;s CEO, Tim Cook would be making a huge investment in America. Following this Apple announced via a press release on Monday morning its investment plans.
Craig Shapiro, the macro strategist at the Bear Traps Report said that this was great for the country in the long term. However, he asked if the company would "trade at the same multiples," and if it was being forced into state-imposed &#8220;capitalism&#8221;.
He further questioned if all the firms would be required to have a meeting with Trump before they make their "capex and hiring decisions".
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Apple forced to &quot;kiss the ring&quot; after meeting with Trump. Great for America longer term but do companies forced into state imposed &quot;capitalism&quot; trade at the same multiples as they have been ? And will other companies now just wait until they have their meeting with Trump… <a href="https://t.co/D5qmSU2pn8">https://t.co/D5qmSU2pn8</a>
&mdash; Craig Shapiro (@ces921) <a href="https://twitter.com/ces921/status/1893983145621369141?ref_src=twsrc%5Etfw">February 24, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: According to Apple's press release with the $500 billion, it plans to manufacture a new server factory in Texas. It aims to double the U.S. Advanced Manufacturing Fund, including silicon production in Arizona and intends to start a manufacturing academy in Michigan. &nbsp;
The iPhone maker also plans to spend on research and development with accelerated investments in AI and silicon engineering nationwide. It wants to expand data centers in North Carolina, Iowa, Oregon, Arizona, and Nevada. Furthermore, it aims to expand its teams and facilities in Michigan, Texas, California, Arizona, Nevada, Iowa, Oregon, North Carolina, and Washington.
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43763438/trump-acting-like-a-mafia-don-says-this-economist-as-uncertainty-mounts-businesses-hold-back-in-fear-of-unforeseen-economic-shifts">Trump &#8216;Acting Like A Mafia Don,&#8217; Says This Economist As Uncertainty Mounts, Businesses Hold Back In Fear Of Unforeseen Economic Shifts</a>
Shapiro in an earlier hypothesis also pointed out that Trump was acting like a "<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43763438/trump-acting-like-a-mafia-don-says-this-economist-as-uncertainty-mounts-businesses-hold-back-in-fear-of-unforeseen-economic-shifts">Mafia Don</a>". He said that the President was making everyone &#8220;kiss the ring&#8221; in order to get advantageous treatment from the U.S. government with respect to tax treatment, tariffs, investment subsidies, mergers approval, etc.
His &#8220;Mafia Don&#8221; metaphor highlights how Trump&#8217;s unpredictable control creates a climate where businesses must wait for approval before moving forward. He said many are left questioning whether investing now is worth the risk. However, the company with the largest market capitalization in the world, Apple became one of the first companies to make huge investment announcements in the U.S.
Price Action: Apple fell 0.70% in premarket on Friday, contrasting with a 0.44% advance in the Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which tracks the Nasdaq 100 index.
AAPL remains higher by 0.70% on a year-to-date basis and 35.54% over a year.
<a href="https://www.benzinga.com/quote/AAPL/analyst-ratings">Benzinga tracks 30 analysts</a> with an average price target of $247.5 for the stock, reflecting a &#8220;buy&#8221; rating. Estimates range widely from $188 to $325. Recent ratings from Citigroup, Needham, and Morgan Stanley average $270, suggesting a potential 11.11% upside.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/AAPL/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="381" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/24070353/Apple-ANR-new-1024x381.png" alt="" class="wp-image-795242" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/24070353/Apple-ANR-new-1024x381.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/24070353/Apple-ANR-new-300x112.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/24070353/Apple-ANR-new-768x286.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/24070353/Apple-ANR-new.png 1063w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43907155/nih-funding-cuts-to-spook-healthcare-stocks-rfk-jrs-confirmation-at-hhs-sparks-concerns-over-research-dollars-causing-uncertainty-says-analyst">NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr&#8217;s Confirmation At HHS Sparks Concerns Over Research Dollars, &#8216;Causing Uncertainty,&#8217; Says Analyst</a></li>
</ul>

Equities

Government

Market Summary

Regulations

Broad U.S. Equity ETFs

Financing

Futures

Markets

Analyst Ratings

ETFs

AAPL

Apple 'Forced To Kiss The Ring'? Expert Questions Whether Trump Pushed The iPhone Maker For $500 Billion Investment

Boston Scientific's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) short percent of float has fallen 27.55% since its last report. The company recently reported that it has 10.45 million shares sold short, which is 0.71% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.65 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Boston Scientific Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740407417_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Boston Scientific has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Boston Scientific's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Boston Scientific's peer group average for short interest as a percentage of float is 3.93%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

What Does the Market Think About Boston Scientific?

Scotiabank analyst Ben Isaacson maintains CF Industries Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CF#NYSE">CF</a>) with a Sector Underperform and lowers the price target from $88 to $81.

Price Target

Scotiabank Maintains Sector Underperform on CF Industries Holdings, Lowers Price Target to $81

Deckers Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) has outperformed the market over the past 5 years by 23.23% on an annualized basis producing an average annual return of 38.38%. Currently, Deckers Outdoor has a market capitalization of $22.43 billion. 
Buying $1000 In DECK: If an investor had bought $1000 of DECK stock 5 years ago, it would be worth $5,071.30 today based on a price of $147.62 for DECK at the time of writing.
<h3>Deckers Outdoor's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740407409_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

DECK

$1000 Invested In Deckers Outdoor 5 Years Ago Would Be Worth This Much Today

Management

QCRH

QCR Holdings CEO Larry Helling To Retire; Todd Gipple To Become President And CEO; Nick Anderson To Be CFO

Scotiabank analyst Mario Saric maintains Boardwalk REIT (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BEI#TSX">BEI</a>) with a Sector Perform and lowers the price target from C$79.5 to C$78.5.

TSX:BEI

TSX:BEI/UN

Scotiabank Maintains Sector Perform on Boardwalk REIT, Lowers Price Target to C$78.5

Truist Securities analyst Mark Hughes initiates coverage on MSC Income Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSIF#NYSE">MSIF</a>) with a Buy rating and announces Price Target of $20.

Initiation

MSIF

Truist Securities Initiates Coverage On MSC Income Fund with Buy Rating, Announces Price Target of $20

<a href="https://www.secretstock.com/mkzr" title="https://www.secretstock.com/mkzr">https://www.secretstock.com/mkzr</a>

MKZR

Mackenzie Realty Capital Paid $225K For Marketing Services Including Two-Day Advertorial Starting February 24, 2025.

Citizens Capital Markets analyst Jonathan Wolleben reiterates Mirum Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIRM#NASDAQ">MIRM</a>) with a Market Outperform and maintains $74 price target.

Reiteration

MIRM

Citizens Capital Markets Reiterates Market Outperform on Mirum Pharmaceuticals, Maintains $74 Price Target

Raymond James analyst Frank Louthan upgrades Uniti Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UNIT#NASDAQ">UNIT</a>) from Outperform to Strong Buy and raises the price target from $6 to $8.

Upgrades

UNIT

Raymond James Upgrades Uniti Group to Strong Buy, Raises Price Target to $8

Raymond James analyst Robert Dodd initiates coverage on MSC Income Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSIF#NYSE">MSIF</a>) with a Market Perform rating.

Raymond James Initiates Coverage On MSC Income Fund with Market Perform Rating

For the second quarter of fiscal 2025, total revenues are expected to be between $675 million and $775 million, adjusted homebuilding gross margin is expected to be between 17.5% and 18.5%, adjusted income before income taxes is expected to be between $20 million and $30 million and adjusted EBITDA is expected to be between $50 million and $60 million.

Guidance

Hovnanian Enterprises Expects Q2 Revenue Of $675M-$775M Vs. $821.8M Est., Adj EBITDA Of $50M-$60M

Asset Sales

Sun Communities Entered Into Agreement To Sell 100% Interest Of Safe Harbor Marinas To Blackstone Infrastructure For $5.65B

Raymond James analyst Stephen Laws downgrades Arbor Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABR#NYSE">ABR</a>) from Outperform to Market Perform.

Downgrades

Raymond James Downgrades Arbor Realty Trust to Market Perform

Citizens Capital Markets analyst David Turkaly reiterates Globus Medical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>) from Market Perform to Market Perform.

GMED

Citizens Capital Markets Reiterates Market Perform on Globus Medicalto Market Perform

Northland Capital Markets analyst Ted Jackson upgrades Toro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTC#NYSE">TTC</a>) from Market Perform to Outperform and maintains the price target from $100 to $100.

Northland Capital Markets Upgrades Toro to Outperform, Maintains Price Target to $100

On Monday, the FDA declined Invivyd, Inc.&#8217;s&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVVD#NASDAQ">IVVD</a>)&nbsp;request to expand the existing emergency use authorization (EUA) for pre-exposure prophylaxis of COVID-19 EUA for Pemgarda (pemivibart) for mild-to-moderate COVID-19 in adults and adolescents who have moderate-to-<a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/g43908842/fda-declined-invivyds-request-to-expand-existing-emergency-use-authorization-of-pemgarda-pemivibar" rel="noreferrer noopener">severe immune compromise</a>.
Existing Pemgarda emergency use for pre-exposure prophylaxis of COVID-19 in certain immunocompromised patients remains in effect.
The company said the COVID-19 treatment opportunity for pemivibart was not contemplated in existing financial guidance.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42920654/whats-going-on-with-covid-19-antibody-developer-invivyd-stock-on-friday" rel="noreferrer noopener">What&#8217;s Going On With COVID-19 Antibody Developer Invivyd Stock On Friday?</a>
FDA&#8217;s reasoning appears to center on a belief that COVID-19 treatment immunobridging analyses for a monoclonal antibody (mAb) must meet a standard of superior antiviral activity rather than equivalent antiviral activity to past, highly effective, previously authorized and now inactive COVID-19 mAbs in a bridging analysis of sVNA1&nbsp;titer levels, otherwise the Agency is &#8220;unable to reasonably conclude that the known and potential benefits of pemivibart…outweigh the known and potential risks&#8221;
In the near term, Invivyd plans to share detailed data and regulatory correspondence regarding pemivibart, VYD2311, and the immunobridging of COVID-19 antibodies.
Earlier this month,&nbsp;Invivyd released new data from the <a target="_blank" href="https://www.benzinga.com/general/biotech/25/02/43438525/invivyd-touts-encouraging-data-from-covid-19-antibody-trial-stock-jumps" rel="noreferrer noopener">ongoing Phase 1/2 trial of VYD2311</a>.
As of Day 65, serum concentrations remain high, potentially substantially increasing the observed half-life of VYD2311 relative to pemivibart, the company's&nbsp;monoclonal antibody&nbsp;medication authorized for the&nbsp;pre-exposure prophylaxis&nbsp;(prevention) of&nbsp;COVID‑19.
Price Action: IVVD stock is down 29.9% at $1.24&nbsp;during the premarket session on last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/asset-sales/25/02/43909136/equitable-inks-reinsurance-deal-with-rga-and-plans-to-boost-stake-in-alliancebernstein-details" target="_blank" rel="noreferrer noopener">Equitable Inks Reinsurance Deal With RGA And Plans To Boost Stake In AllianceBernstein: Details</a></li>
</ul>
Photo: Shutterstock

Health Care

Movers

IVVD

FDA Rejects Invivyd's Request To Expand Emergency Authorization For Preventive COVID-19 Antibody For Immunocompromised Patients

Press Releases

Zhongchao Inc. Announces 1-for-10 Share Consolidation

Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications

ZCMD

ATA Creativity Global - American Depositary Shares, each representing two common shares

ATA Creativity Glb

Ambow Education Holding Ltd. American Depository Shares (each representing twenty (20) Class A Ordinary Shares)

Ambow Education Holding

Amesite

American Public Education, Inc. - Common Stock

American Public Education

Bright Scholar Education Holdings Limited American Depositary Shares, each representing four Class A Ordinary Share

Bright Scholar Education

Chegg

China Liberal Education Holdings Limited - Ordinary Shares

China Liberal Education

51Talk Online Education Group American depositary shares, each representing 60 Class A ordinary shares

51 Talk Online Education

Skillful Craftsman Education Technology Limited - Ordinary Share

Skillful Craftsman

EpicQuest Education Group International Limited - Common Stock

EpicQuest Education Group

Genius Gr

Visionary Holdings

Jiade

Jianzhi Education Technology Group Company Limited - American Depositary Shares

Jianzhi Education Tech

Legacy Education

Lixiang Education Holding Co., Ltd. - American Depositary Shares

Lixiang Education Hldg

Mynd.ai

Jinxin Technology Holding Company - American Depositary Shares

Jinxin Technology Holding

Nerdy

NETCLASS TECHNOLOGY INC - Class A Ordinary Shares

Netclass Technology

QuantaSing Group Limited - American Depositary Shares

QuantaSing Group

Sunlands Technology Group American Depositary Shares, representing Class A ordinary shares

Comments

ZHONGCHAO

Noticias

Últimas noticias sobre ZHONGCHAO (NASDAQ:ZCMD) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL